The partnership with LTS Therapy Systems to develop and manufacture the HT-ALZ oral film prototype is a significant step for Hoth Therapeutics in advancing its Alzheimer's disease treatment. This development could positively impact HOTH's stock price in the short term as it shows progress in their product pipeline.